False Claims Act

From Wikipedia, the free encyclopedia - View original article

Jump to: navigation, search

The False Claims Act (31 U.S.C. §§ 37293733, also called the "Lincoln Law") is an American federal law that imposes liability on persons and companies (typically federal contractors) who defraud governmental programs. It is the federal Government’s primary tool in combating fraud against the Government.[1] Today, over 70 percent of all federal Government FCA actions are initiated by whistleblowers.[2] The law includes a "qui tam"[3] provision that allows people[4] who are not affiliated with the government to file actions on behalf of the government (informally called "whistleblowing").[5] Persons filing under the Act stand to receive a portion[6] (usually about 15–25 percent) of any recovered damages. Claims under the law have typically involved health care, military, or other government spending programs, and dominate the list of largest pharmaceutical settlements. The government has recovered nearly $35 billion under the False Claims Act between 1987 (after the significant 1986 amendments) and 2012.[7] Of this amount, over $24 billion or 70% was from qui tam cases brought by relators.[8]


Qui tam laws have history dating back to the Middle Ages in England. In 1318, King Edward II offered one third of the penalty to the relator when the relator successfully sued government officials who moonlighted as wine merchants.[9] The Maintenance and Embracery Act 1540 of Henry VIII provided that common informers could sue for certain forms of interference with the course of justice in legal proceedings that were concerned with the title to land.[10] This act is still in force today in the Republic of Ireland, although in 1967 it was extinguished in England. The idea of a common informer bringing suit for damages to the Commonwealth was later brought to Massachusetts, where "penalties for fraud in the sale of bread [are] to be distributed one third to inspector who discovered the fraud and the remainder for the benefit of the town where the offense occurred."[9] Other statutes can be found on the colonial law books of Connecticut, New York, Virginia and South Carolina.[9]

The American Civil War (1861–1865) was marked by fraud on all levels, both in the Union north and the Confederate south. During the war, unscrupulous contractors sold the Union Army decrepit horses and mules in ill health, faulty rifles and ammunition, and rancid rations and provisions, among other unscrupulous actions.[11] In response, Congress passed the False Claims Act on March 2, 1863, 12 Stat. 696.[12] Because it was passed under the administration of President Abraham Lincoln, the False Claims Act is often referred to as the "Lincoln Law".[13]

Importantly, a reward was offered in what is called the qui tam provision, which permits citizens to sue on behalf of the government and be paid a percentage of the recovery. Qui tam is an abbreviated form of the Latin legal phrase qui tam pro domino rege quam pro se ipso in hac parte sequitur ("he who brings a case on behalf of our lord the King, as well as for himself")[14] In a qui tam action, the citizen filing suit is called a "relator".[15] As an exception to the general legal rule of standing, courts have held that qui tam relators are "partially assigned" a portion of the government's legal injury, thereby allowing relators to proceed with their suits.[16]

U.S. Senator Jacob M. Howard, who sponsored the legislation, justified giving rewards to whistle blowers, many of whom had engaged in unethical activities themselves. He said, “I have based the [qui tam provision] upon the old-fashioned idea of holding out a temptation, and ‘setting a rogue to catch a rogue,’ which is the safest and most expeditious way I have ever discovered of bringing rogues to justice.”[17]


The Act establishes liability when any person or entity improperly receives from or avoids payment to the Federal government (tax fraud is excepted). The Act prohibits:

  1. Knowingly presenting, or causing to be presented a false claim for payment or approval;
  2. Knowingly making, using, or causing to be made or used, a false record or statement material to a false or fraudulent claim;
  3. Conspiring to commit any violation of the False Claims Act;
  4. Falsely certifying the type or amount of property to be used by the Government;
  5. Certifying receipt of property on a document without completely knowing that the information is true;
  6. Knowingly buying Government property from an unauthorized officer of the Government, and;
  7. Knowingly making, using, or causing to be made or used a false record to avoid, or decrease an obligation to pay or transmit property to the Government.

The most commonly used of these provisions are the first and second, prohibiting the presentation of false claims to the government and making false records to get a false claim paid. By far the most frequent cases involve situations in which a defendant—usually a corporation but on occasion an individual—overcharges the federal government for goods or services. Other typical cases entail failure to test a product as required by the rigorous government specifications or selling defective products.

The False Claims Act was amended in 1943 to, most notably, reduce the relator's share of the recovered proceeds.* The law was again amended in 1986. By that time, there was great concern that the national deficit had risen dangerously and President Ronald Reagan had declared that a vast amount of government spending was being misused through waste and fraud.

After the 1986 amendments strengthening the Act were passed (see below), the Act was used primarily against defense contractors. By the late 1990s, however, the focus had shifted to health care fraud, which now accounts for the majority of cases filed by whistleblowers and by the government.[8]

Under the False Claims Act, the Department of Justice is authorized to pay rewards to those who report fraud against the federal government in an amount of between 15 and 30 percent of what it recovers based upon the whistleblower's report. The overall average percentage of awards is 17%.[18] In 1996, the DOJ developed a set of factors for determining the relator’s share, referred to as the Relator’s Share Guidelines (DOJ Guidelines).[19]

Certain claims are not actionable, including:

  1. certain actions against armed forces members, members of the United States Congress, members of the judiciary, or senior executive branch officials;[20]
  2. claims, records, or statements made under the Internal Revenue Code of 1986 which would include tax fraud;[21]

There are unique procedural requirements in False Claims Act cases. For example:

  1. a complaint under the False Claims Act must be filed under seal;[22]
  2. the complaint must be served on the government but must not be served on the defendant;[22]
  3. the complaint must be buttressed by a comprehensive memorandum, not filed in court, but served on the government detailing the factual underpinnings of the complaint.[23]

In addition, the FCA contains an anti-retaliation provision, which allows a relator to recover, in addition to his award for reporting fraud, double damages plus attorney fees for any acts of retaliation for reporting fraud against the Government.[24] This provision specifically provides relators with a personal claim of double damages for harm suffered and reinstatement.[25]

1986 changes[edit]

(False Claims Act Amendments (Pub.L. 99–562, 100 Stat. 3153, enacted October 27, 1986)

  1. The elimination of the "government possession of information" bar against qui tam lawsuits;
  2. The establishment of defendant liability for "deliberate ignorance" and "reckless disregard" of the truth;
  3. Restoration of the "preponderance of the evidence" standard for all elements of the claim including damages;
  4. Imposition of treble damages and civil fines of $5,000 to $10,000 per false claim;
  5. Increased rewards for qui tam plaintiffs of between 15–30 percent of the funds recovered from the defendant;
  6. Defendant payment of the successful plaintiff's expenses and attorney's fees, and;
  7. Employment protection for whistleblowers including reinstatement with seniority status, special damages, and double back pay.

2009 changes[edit]

On May 20, 2009, the Fraud Enforcement and Recovery Act of 2009 (FERA) was signed into law. It includes the most significant amendments to the FCA since the 1986 amendments. FERA enacted the following changes:

  1. Expanded the scope of potential FCA liability by eliminating the "presentment" requirement (effectively overruling the Supreme Court's opinion in Allison Engine Co. v. United States ex rel. Sanders, 128 S. Ct. 2123 (2008));
  2. Redefined "claim" under the FCA to mean "any request or demand, whether under a contract or otherwise for money or property and whether or not the United States has title to the money or property" that is (1) presented directly to the United States, or (2) "to a contractor, grantee, or other recipient, if the money or property is to be spent or used on the Government's behalf or to advance a Government program or interest" and the government provides or reimburses any portion of the requested funds;
  3. Amended the FCA's intent requirement, and now requiring only that a false statement be "material to" a false claim;
  4. Expanded conspiracy liability for any violation of the provisions of the FCA;
  5. Amended the "reverse false claims" provisions to expand liability to "knowingly and improperly avoid[ing] or decreas[ing] an obligation to pay or transmit money or property to the Government;"
  6. Increased protection for qui tam plaintiffs/relators beyond employees, to include contractors and agents;
  7. Procedurally, the government's complaint will now relate back to the qui tam plaintiff/relator's filing;
  8. Provided that whenever a state or local government is named as a co-plaintiff in an action, the government or the relator "shall not [be] preclude[d]... from serving the complaint, any other pleadings, or the written disclosure of substantially all material evidence;"
  9. Increased the Attorney General's power to delegate authority to conduct Civil Investigative Demands prior to intervening in an FCA action.

With this revision, the FCA now prohibits knowingly (changes are in bold):

  1. Submitting for payment or reimbursement a claim known to be false or fraudulent.
  2. Making or using a false record or statement material to a false or fraudulent claim or to an ‘obligation’ to pay money to the government.
  3. Engaging in a conspiracy to defraud by the improper submission of a false claim.
  4. Concealing, improperly avoiding or decreasing an ‘obligation’ to pay money to the government.

2010 changes under the Patient Protection and Affordable Care Act[edit]

On March 23, 2010, the Patient Protection and Affordable Care Act (also referred to as the health reform bill or PPACA) was signed into law by President Barack Obama. The Affordable Care Act made further amendments to the False Claims Act, including:

  1. Changes to the Public Disclosure Bar. Under the previous version of the FCA, cases filed by private individuals or “relators” could be barred if it was determined that such cases were based on a public disclosure of information arising from certain proceedings, such as civil, criminal or administrative hearings, or news media reports. As a result, defendants frequently used the public disclosure bar as a defense to a plaintiff’s claims and grounds for dismissal of the same. PPACA amended the language of the FCA to allow the federal government to have the final word on whether a court may dismiss a case based on a public disclosure. The language now provides that “the court shall dismiss an action unless opposed by the Government, if substantially the same allegations or transaction alleged in the action or claim were publicly disclosed.” See 31 U.S.C. 3730(e)(4)(A).
  2. Original Source Requirement. A plaintiff may overcome the public disclosure bar outlined above if they qualify as an “original source,” the definition of which has also been revised by PPACA. Previously, an original source must have had “direct and independent knowledge of the information on which the allegations are based.” Under PPACA, an original source is now someone who has “knowledge that is independent of and materially adds to the publicly disclosed allegations or transactions.” See 31 U.S.C. 3730(e)(4)(B).
  3. Overpayments. FERA redefined “obligation” under the FCA to include “retention of any overpayments.” Accordingly, such language imposed FCA liability on any provider who received Medicare/Medicaid overpayments (accidentally or otherwise) and fails to return the money to the government. However, FERA also raised questions as to what exactly is involved in the “retention of overpayments” – for example, how long a provider had to return monies after discovering an overpayment. PPACA clarified the changes to the FCA made by FERA. Under PPACA, overpayments under Medicare and Medicaid must be reported and returned within 60 days of discovery, or the date a corresponding hospital report is due. Failure to timely report and return an overpayment exposes a provider to liability under the FCA.
  4. Statutory Anti-Kickback Liability. The federal Anti-Kickback Statute, 42 U.S.C. 1320a-7b(b) (AKS) is a criminal statute which makes it improper for anyone to solicit, receive, offer or pay remuneration (monetary or otherwise) in exchange for referring patients to receive certain services that are paid for by the government. Previously, many courts had interpreted the FCA to mean that claims submitted as a result of AKS violations were false claims and therefore gave rise to FCA liability (in addition to AKS penalties). However, although this was the “majority rule” among courts, there were always opportunities for courts to hold otherwise. Importantly, PPACA changed the language of the AKS to provide that claims submitted in violation of the AKS automatically constitute false claims for purposes of the FCA. Further, the new language of the AKS provides that “a person need not have actual knowledge … or specific intent to commit a violation” of the AKS. Accordingly, providers will not be able to successfully argue that they did not know they were violating the FCA because they were not aware the AKS existed.

Practical application of the law[edit]

The False Claims Act has a detailed process for making a claim under the Act. Mere complaints to the government agency are insufficient to bring claims under the Act. A complaint (lawsuit) must be filed in U.S. District Court (federal court) in camera (under seal). After an investigation by the Department of Justice within 60 days, or frequently several months after an extension is granted, the Department of Justice decides whether it will pursue the case.

If the case is pursued, the amount of the reward is less than if the Department of Justice decides not to pursue the case and the plaintiff/relator continues the lawsuit himself. However, the success rate is higher in cases that the Department of Justice decides to pursue.

Technically, the government has several options in handing cases. These include:

  1. intervene in one or more counts of the pending qui tam action. This intervention expresses the Government’s intention to participate as a plaintiff in prosecuting that count of the complaint. Fewer than 25% of filed qui tam actions result in an intervention on any count by the Department of Justice.
  2. decline to intervene in one or all counts of the pending qui tam action. If the United States declines to intervene, the relator may prosecute the action on behalf of the United States, but the United States is not a party to the proceedings apart from its right to any recovery. This option is frequently used by relators and their attorneys.
  3. move to dismiss the relator’s complaint, either because there is no case, or the case conflicts with significant statutory or policy interests of the United States.

In practice, there are two other options for the Department of Justice:

  1. settle the pending qui tam action with the defendant prior to the intervention decision. This usually, but not always, results in a simultaneous intervention and settlement with the Department of Justice (and is included in the 25% intervention rate).
  2. advise the relator that the Department of Justice intends to decline intervention. This usually, but not always, results in dismissal of the qui tam action, according to the U.S. Attorneys' Office of the Eastern District of Pennsylvania.[26]

There is case law where claims may be prejudiced if disclosure of the alleged unlawful act has been reported in the press, if complaints were filed to an agency instead of filing a lawsuit, or if the person filing a claim under the act is not the first person to do so. Individual states in the U.S. have different laws regarding whistleblowing involving state governments.

Taxation of awards under FCA[edit]

On November 8, 2001, in Alderson, v. United States, the Ninth Circuit held the reward was "not entitled to capital gain treatment" and was ordinary income for services.[27] However, Robert W. Wood and Dashiell C. Shapiro argue the FCA statute says "that the relator has a property right to the information and documents that form the basis of the qui tam action" and that "represents a payment for the exchange of the information and documents", which "FCA's statutory scheme strongly suggests that the relator's recovery is capital" gain because the "bulk of the award is for the information property transferred, not for services rendered".[27]

Relevant decisions by the United States Supreme Court[edit]

In a 2000 case, Vermont Agency of Natural Resources v. United States ex rel. Stevens, 529 U.S. 765 (2000),[28] the United States Supreme Court held that a private individual may not bring suit in federal court on behalf of the United States against a State (or state agency) under the FCA. In Stevens, the Supreme Court also endorsed the "partial assignment" approach to qui tam relator standing to sue, which had previously been articulated by the Ninth Circuit Federal Court of Appeals and is an exception to the general legal rule for standing.[29]

In a 2007 case, Rockwell International Corp. v. United States, the United States Supreme Court considered several issues relating to the "original source" exception to the FCA's public-disclosure bar. The Court held that (1) the original source requirement of the FCA provision setting for the original-source exception to the public-disclosure bar on federal-court jurisdiction is jurisdictional; (2) the statutory phrase "information on which the allegations are based" refers to the relator's allegations and not the publicly disclosed allegations; the terms "allegations" is not limited to the allegations in the original complaint, but includes, at a minimum, the allegations in the original complaint as amended; (3) relator's knowledge with respect to the pondcrete fell short of the direct and independent knowledge of the information on which the allegations are based required for him to qualify as an original source; and (4) the government's intervention did not provide an independent basis of jurisdiction with respect to the relator.

In a 2008 case, Allison Engine Co. v. United States ex rel. Sanders, the United States Supreme Court considered whether a false claim had to be presented directly to the Federal government, or if it merely needed to be paid with government money, such as a false claim by a subcontractor to a prime contractor. The Court found that the claim need not be presented directly to the government, but that the false statement must be made with the intention that it will be relied upon by the government in paying, or approving payment of, a claim.[30] The Fraud Enforcement and Recovery Act of 2009 reversed the Court's decision and made the types of fraud to which the False Claims Act applies more explicit.[31]

In a 2009 case, United States ex rel. Eisenstein v. City of New York,[32] the United States Supreme Court considered whether, when the government declines to intervene or otherwise actively participate in a qui tam action under the False Claims Act, the United States is a "party" to the suit for purposes of Federal Rule of Appellate Procedure 4(a)(1)(A) (which requires that a notice of appeal in a federal civil action generally be filed within 30 days after entry of a judgment or order from which the appeal is taken). The Court held that when the United States has declined to intervene in a privately initiated FCA action, it is not a "party" for FRAP 4 purposes, and therefore, petitioner's appeal filed after 30 days was untimely.

State False Claims Acts and application in other jurisdictions[edit]

Twenty-nine states and the District of Columbia[33] have also created false-claims statutes to protect their publicly funded programs from fraud by including qui tam provisions, which enables them to recover money at state level.[34] Twenty of these state False Claims Act statutes provide similar protections to those of the federal law, while ten states have laws which limit recovery to claims of fraud related to the Medicaid program.[33]

The California False Claims Act was enacted in 1987, but lay relatively dormant until the early 1990s, when public entities, frustrated by what they viewed as a barrage of unjustified and unmeritorious claims, began to employ the False Claims Act as a defensive measure. Recent developments in the California False Claims Act reduce the defenses contractors have to false claim prosecutions, by stripping away immunities that were believed to apply to certain classes of statements and claims. As a result, contractors can expect to see their payment claims answered by false claims accusations with increasing frequency.

It has recently been argued that legislation modeled on the False Claims Act should be introduced in Australia and apply to the tobacco industry and carbon pricing schemes[35] among others in an effort to save the Australian government millions, if not billions, of dollars currently being lost to contractor fraud.[36]

In October 2013, the UK Government announced that it is considering the case for financially incentivising individuals reporting fraud in economic crime cases by private sector organisations, in an approach much like the US False Claims Act.[37] The 'Serious and Organised Crime Strategy' paper released by the UK's Secretary of State for the Home Department sets out how that government plans to take action to prevent serious and organised crime and strengthen protections against and responses to it. The paper asserts that serious and organised crime costs the UK more than £24 billion a year. In the context of anti-corruption, the paper acknowledges that there is a need to not only target serious and organised criminals but also support those who seek to help identify and disrupt serious and organised criminality. Three UK agencies (the Department for Business, Innovation & Skills), the Ministry of Justice and the Home Office have been tasked with considering the case for a US-style False Claims Act in the UK. It is argued that Australia will be watching the steps taken by the UK in this regard carefully.[38]

Rule 9(b) circuit split[edit]

Under Rule 9(b) of the Federal Rules of Civil Procedure, allegations of fraud or mistake must be pleaded with particularity.[39] The application of the Rule 9(b) pleading standard to claims made under the False Claims Act, however, has generated much litigation, and there remains a split among the federal appeals courts surrounding the specificity of the factual matter which needs to be alleged in order to plead a sufficient False Claims Act complaint. While the First Circuit,[40] and the Seventh Circuit[41] have ruled that whistleblowers under the False Claims Act are not required to allege specific false claims to satisfy Rule 9(b), the Fifth Circuit,[42] Eleventh Circuit,[43] the Sixth Circuit,[44] the Eighth Circuit,[45] and the Tenth Circuit[46] have all found that plaintiffs must allege specific false claims.

In 2010, the First Circuit decision in U.S. ex rel. Duxbury v. Ortho Biotech Prods., L.P.(2009) and the Eleventh Circuit ruling in U.S. ex rel. Hopper v. Solvay Pharms., Inc.(2009) were both appealed to the U.S. Supreme Court. The Court denied certiorari for both cases, however, declining to resolve the divergent appeals court decisions.[47][48]

ACLU et al. v. Holder[edit]

The American Civil Liberties Union (ACLU), Government Accountability Project (GAP) and OMB Watch commenced the lawsuit seeking to have the provision of the law that permits whistleblowers to file their cases confidentially declared unconstitutional. The Department of Justice and other whistleblower protection groups opposed the lawsuit. The Appeals Court rejected the plaintiffs' claims on March 28, 2011. The National Whistleblowers Center (NWC) publicly asked the three plaintiffs in the court case ACLU et al. v. Holder not to appeal the decision of the U.S. Court of Appeals for the Fourth Circuit dismissing their challenge to a key provision of the False Claims Act (FCA)[49]


In 2010, a subsidiary of Johnson & Johnson agreed to pay over $81 million in civil and criminal penalties to resolve allegations in a FCA suit filed by two whistleblowers. The suit alleged that Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI) acted improperly concerning the marketing, promotion and sale of the anti-convulsant drug Topamax. Specifically, the suit alleged that OMJPI "illegally marketed Topamax by, among other things, promoting the sale and use of Topamax for a variety of psychiatric conditions other than those for which its use was approved by the Food and Drug Administration, (i.e., "off-label" uses)." It also states that "certain of these uses were not medically accepted indications for which State Medicaid programs provided coverage" and that as a result "OMJPI knowingly caused false or fraudulent claims for Topamax to be submitted to, or caused purchase by, certain federally funded healthcare programs.

Two qui tam lawsuits brought by whistleblowers (“Relators”) under the provisions of the Federal False Claims Act (FCA) has resulted in a significant recovery for taxpayers. The $22 Million state and federal recovery resolves the Relators allegations that Schwarz Pharma Inc. and its subsidiary Kremers Urban, LLC sold drugs to Medicaid that had never been approved by the Food and Drug Administration for safety and effectiveness as required by law. Pursuant to the settlement, the two whistleblowers will receive a total of $1,836,575 from the federal share and additional amounts from the states. The settlement resolves allegations against Schwarz in two separate multi-defendant whistleblower actions captioned United States ex rel. Constance Conrad v. Schwarz Pharma, et al., No. 02-11738-NG (D. Mass.),[50] and United States ex rel. James Conrad v. Kremers Urban, et al., Civil No. 08-cv-428 (S.D. Tex.).[51]

In response to a complaint from whistleblower Jerry H. Brown II, the US Government filed suit against Maersk for overcharging for shipments to US forces fighting in Iraq and Afghanistan. In a settlement announced on 3 January 2012, the company agreed to pay $31.9 million in fines and interest, but made no admission of wrongdoing. Brown was entitled to $3.6 million of the settlement.[52][53]

See also[edit]


  1. ^ United States ex rel. Steury v. Cardinal Health, Inc., 625 F.3d 262, 267 (5th Cir.2010); (“The FCA is the Government's primary litigation tool for recovering losses resulting from fraud.”)
  2. ^ Hesch, Breaking the Siege: Restoring Equity and Statutory Intent to the Process of Determining Qui Tam Relator Awards Under the False Claims Act, 29 T.M. COOLEY L. REV. 217, 229 (2012) (“Whistleblower qui tam suits have become the Government’s chief anti-fraud tool and account for about 70% of all funds the DOJ recovers from defrauders.”).
  3. ^ Qui tam is short for the Latin phrase “qui tam pro domino rege quam pro se ipso in hac parte sequitur,” which means “who as well for the king as for himself sues in this matter.” Vt. Agency of Natural Res. v. United States ex rel. Stevens, 529 U.S. 765, 769 n.1 (2000).
  4. ^ The whistleblower is known as a “relator” because he is one who relates the fraud action on behalf of the Government. United States ex rel. Karvelas v. Melrose-Wakefield Hosp., 360 F.3d 220, 225 (1st Cir. 2004)
  5. ^ (“A ‘relator’ is ‘[a] party in interest who is permitted to institute a proceeding in the name of the People or the Attorney General when the right to sue resides solely in that official.’ Black’s Law Dictionary 1289 (6th ed. 1990).”)
  6. ^ Brown, Howard. "Whistleblower Claim Rewards". 
  7. ^ Fraud Statistics – Overview, Oct. 1, 1987 – Sept. 30, 2012, U.S. DEP’T OF JUSTICE (Oct. 24, 2012), http://www.taf.org/DoJ-FCA-statistics-2012.pdf. Comprehensive information regarding FCA statistics may be found at http://www.taf.org/statistics.htm, including information regarding recoveries in individual cases.
  8. ^ a b Fraud Statistics – Overview, Oct. 1, 1987 – Sept. 30, 2012, U.S. DEP’T OF JUSTICE (Oct. 24, 2012), http://www.taf.org/DoJ-FCA-statistics-2012.pdf.
  9. ^ a b c C. Doyle, writing for the Congressional Research Service (2009): "Qui Tam: The False Claims Act and Related Federal Statutes"
  10. ^ The Law Commission. Proposals to Abolish Certain Ancient Criminal Offences. HMSO. 1966. Paragraph 6(a) at page 4.
  11. ^ Larry D. Lahman, "Bad Mules: A Primer on the Federal False Claims Act", 76 Okla. B. J. 901, 901 (2005) https://www.michbar.org/journal/pdf/pdf4article1590.pdf
  12. ^ Hubbard v. United States, 514 U.S. 695 (1995), at 704
  13. ^ "Qui Tam A History". Whistleblower Info. Retrieved 2012-01-23. 
  14. ^ Vt. Agency of Natural Res. v. United States ex rel. Stevens, 529 U.S. 765, 769 n.1 (2000).
  15. ^ A relator is one who relates the fraud action on behalf of the Government. See United States ex rel. Karvelas v. Melrose-Wakefield Hosp., 360 F.3d 220, 226 n.7 (1st Cir. 2004).
  16. ^ See Nathan D. Sturycz, The King and I?: An Examination of the Interest Qui Tam Relators Represent and the Implications for Future False Claims Act Litigation, 28 St. Louis Pub. L. Rev. 459 (2009), available at http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1537749
  17. ^ Vt. Agency of Natural Res. v. United States ex rel. Stevens, 529 U.S. 765, 769 n.1 (2000); see also "When Bad Things Happen to Good Rogues". Pacific Standard. Retrieved 29 August 2013. 
  18. ^ One Click Statistics Sheet, TAXPAYERS AGAINST FRAUD EDUC. FUND, http://www.taf.org/statistics.htm (last visited Oct. 7, 2011).
  19. ^ DOJ Relator’s Share Guidelines, FALSE CLAIMS ACT & QUI TAM Q. REV. (Oct. 1997), at 17–19, available at http://www.taf.org/publications/PDF/oct97qr.pdf.
  20. ^ "Federal False Claims Act – 31 U.S.C. § 3730(e)(1) and (2)". Qui Tam Guide. Retrieved 2008-05-04.  (31 U.S.C. § 3730)
  21. ^ "Federal False Claims Act – 31 U.S.C. § 3729(e)". Qui Tam Guide. Retrieved 2008-05-04.  (31 U.S.C. § 3729)
  22. ^ a b 31 U.S.C. § 3730(b)(2).
  23. ^ The FCA requires each relator to supply the Government with a statement of material evidence (“SME”) containing all information and documents they possess that support the FCA allegations. 31 U.S.C. § 3730(b)(2).
  24. ^ 31 U.S.C. § 3720(h). To prevail on a § 3730(h) retaliation claim, the relator must establish these three elements: (1) the employee was engaging in conduct protected by the FCA, (2) the employer knew the employee was engaging in protected conduct, and (3) the employer discriminated against the employee because of his or her protected conduct. Id.
  25. ^ 31 U.S.C. § 3730(h).
  26. ^ False Claims Act Cases: Government intervention in Qui Tam (whistleblower) suits – Memo of the U.S. Attorneys' Office of the Eastern District of Pennsylvania
  27. ^ a b 2013 TNT 234-7 (December 2013). "2013 TNT 234-7 BLOWING THE WHISTLE ON TAXING WHISTLEBLOWER RECOVERIES. (Section 62 -- Adjusted Gross Income) (Release Date: NOVEMBER 18, 2013) (Doc 2013-26589)". Tax Analysts. 
  28. ^ Text of Vermont Agency of Natural Resources v. United States ex rel. Stevens
  29. ^ Vermont Agency of Natural Resources v. United States ex rel. Stevens, 529 U.S. 765 (2000)Text of Vermont Agency of Natural Resources v. United States ex rel. Stevens; see also Nathan D. Sturycz, The King and I?: An Examination of the Interest Qui Tam Relators Represent and the Implications for Future False Claims Act Litigation, 28 St. Louis Pub. L. Rev. 459 (2009), available at http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1537749. For the general standing rule, see Lujan v. Defenders of Wildlife, 504 U.S. 555 (1992)
  30. ^ Opinion of the Court, Allison Engine Co. v. United States ex rel. Sanders, 553 U. S. __ (2008), part II(C).
  31. ^ Senate Judiciary Committee (March 23, 2009). "Senate Report 111-10, part III". Retrieved 2009-05-26. "This section amends the FCA to clarify and correct erroneous interpretations of the law that were decided in Allison Engine Co. v. United States ex rel. Sanders, 128 S. Ct. 2123 (2008), and United States ex. rel. Totten v. Bombardier Corp, 380 F.3d 488 (D.C. Cir. 2004)." 
  32. ^ http://www.supremecourt.gov/opinions/08pdf/08-660.pdf
  33. ^ a b Taxpayers Against Fraud
  34. ^ James F. Barger Jr., Pamela H. Bucy, Melinda M. Eubanks, Marc A. Raspanti, "States, Statutes, and Fraud: An Empirical Study of Emerging State False Claims Acts," Tulane Law Review (2005).
  35. ^ Thomas A Faunce, Gregor Urbas and Lesley Skillen. Implementing US-style anti-fraud laws in the Australian pharmaceutical and health care industries. Med J Aust 2011; 194 (9): 474-478. http://www.mja.com.au/public/issues/194_09_020511/fau11387_fm.html (accessed 2 May 2011)
  36. ^ Ben Allen, "Pay the piper, and we may end public fraud", Sydney Morning Herald, 7 May 2013. http://www.smh.com.au/national/public-service/pay-the-piper-and-we-may-end-public-fraud-20130503-2iz0o.html
  37. ^ https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/248645/Serious_and_Organised_Crime_Strategy.pdf
  38. ^ Ben Allen, "UK now considering a False Claims Act: is Australia next?", October 2013 http://www.nortonrosefulbright.com/au/knowledge/publications/106954/uk-now-considering-a-false-claims-act-is-australia-next
  39. ^ Fed.R.Civ.P. 9(b)
  40. ^ http://www.harvardlawreview.org/media/pdf/duxbury_v_ortho_biotech_products.pdf
  41. ^ http://caselaw.findlaw.com/us-7th-circuit/1149995.html
  42. ^ http://www.ca5.uscourts.gov/opinions/pub/12/12-10858-CV0.pdf
  43. ^ http://www.ca11.uscourts.gov/opinions/ops/200815810.pdf
  44. ^ http://www.ca6.uscourts.gov/opinions.pdf/06a0161p-06.pdf
  45. ^ http://www.ca8.uscourts.gov/opndir/11/05/101784P.pdf
  46. ^ http://caselaw.findlaw.com/us-10th-circuit/1080281.html
  47. ^ Ortho Biotech Prods., L.P. v. United States ex rel. Duxbury, 78 U.S.L.W. 3361 (U.S. June 21, 2010) (denial of certiorari)
  48. ^ United States ex rel. Hopper v. Solvay Pharms., Inc., 78 U.S.L.W. 3531 (U.S. June 21, 2010) (denial of certiorari)
  49. ^ Whistleblower Group Asks Plaintiffs Not to Appeal the Fourth Circuit's ACLU v. Holder Decision http://www.whistleblowers.org/index.php?option=com_content&task=view&id=1209&Itemid=178
  50. ^ http://false-claims-act.net/eon-labs-pays-us-35-million-to-settle-medicaid-false-claims-allegations-in-qui-tam-case-brought-by-nolan-and-auerbach-pa-client/
  51. ^ http://www.justice.gov/opa/pr/2010/February/10-civ-171.html
  52. ^ Egelko, Bob, "$31.9 Million Settlement In Shipping Suit", San Francisco Chronicle, 4 January 2012, P. D1.
  53. ^ USDOJ: "Maersk Line to Pay Us $31.9 Million to Resolve False Claims Allegations for Inflated Shipping Costs to Military in Afghanistan and Iraq" 3 Jan 2012
  54. ^ redding111505

External links[edit]